The second expressed higher levels of INHBA and CD142 and was able to differentiate more efficiently into myofibroblasts in a TGFβ-dependent manner, or to Myo-CAFs in the presence of breast cancer cells, as evidenced by expressions of αSMA and N-cadherin. The gene discussed is F3; the disease is breast carcinoma.